Compass Point lowered the firm’s price target on Physicians Realty Trust to $18 from $19 and keeps a Buy rating on the shares. The firm says its 2024 operating income estimate was higher than management’s projection and that there is always execution risk involved in combining business operations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DOC:
